Dedifferentiating Breast Luminal Cells to Mammary Stem Cells
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods are inefficient and costly for obtaining sufficient quantities of human multipotent mammary stem cells capable of differentiating into various cell types, and there is a need for a reliable source of cells for tissue engineering, cell therapeutics, and breast cancer therapies, with ethical concerns surrounding stem cell isolation from embryos or fetal tissue.
Innovation Solution
A method involving the isolation and in-vitro growth of primary breast luminal cells, treated with conditioned medium from active breast stromal fibroblasts or interleukin-8, followed by growth in specific media to form mammospheres, which are then transferred to stem cell growth medium to generate multipotent mammary stem cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If stem cells are isolated from embryos or fetal tissue, then sufficient quantities of stem cells can be obtained, but ethical concerns arise and the process becomes costly and complex
Solution Approach 1:
Instead of isolating stem cells from embryos or fetal tissue (traditional approach), the invention inverts the process by dedifferentiating fully differentiated adult breast luminal cells into multipotent mammary stem cells. This reverse approach avoids ethical concerns and the complexity of embryonic stem cell isolation while achieving the same goal of obtaining sufficient quantities of stem cells for therapeutic applications.
2Reliability
If conventional methods are used to obtain stem cells, then the process is costly and time-consuming, but the quality and multipotency of obtained cells may be insufficient
Solution Approach 1:
The invention changes the parameters of the cell culture system by using specific growth factors (EGF, bFGF, insulin, hydrocortisone), defined serum-free medium compositions, and controlled culture conditions to induce dedifferentiation of luminal cells into multipotent stem cells. This parameter optimization ensures high quality, multipotent cells are obtained efficiently without the time loss associated with conventional isolation methods.
Solution Approach 2:
The invention performs preliminary expansion of breast luminal cells in defined culture conditions before inducing dedifferentiation. This preliminary action ensures sufficient cell numbers are available for the dedifferentiation process, reducing the overall time required compared to attempting direct isolation and expansion from primary tissue samples.
3Productivity
If primary breast luminal cells are directly used for therapy, then ethical concerns are avoided, but these cells lack the proliferative and differentiation capacity of true stem cells
Solution Approach 1:
The invention dynamically controls the differentiation state of breast cells by adjusting culture conditions. Primary luminal cells are first expanded in luminal-specific growth conditions, then the culture parameters are changed (serum-free medium with specific growth factors) to induce dedifferentiation into multipotent stem cells. This dynamic control allows the cells to gain proliferative capacity while maintaining ease of manufacture through defined culture protocols.
Data Source
AI summary
The invention relates to methods for generating multipotent mammary stern cells from isolated and cultured human breast luminal cells. The method comprises the steps: 1. isolating and growing normal differentiated cells in vitro; 2. treating the differentiated cells with either a conditioned medium from active fibroblasts or cytokine. The invention also relates to multipotent mammary stem cells, cultures of the multipotent stem cells, differentiated cells, tissues, organs derived from the culture multipotent stem cells isolated by the methods disclosed and therapeutic and other uses for those cells thereof.